Using the time for innovation and the right setup
Corona has influence in all areas of working life. Celsius42 GmbH also has to deal with it and has finished the first half of the year with the best result in the company's history. This is a…
News
Data suggest chemotherapy, anticancer treatments not significant contributors to worse outcomes in cancer patients with COVID-19
An analysis published in The Lancet of the largest cohort presented so far of cancer patients with coronavirus disease 2019 (COVID-19) has concluded that recent chemotherapy use is not a significant…
Celsius42 and hyperthermia on the advance in Asia
Charting a new course for cancer treatment in Asia Celsius42 GmbH has been represented in parts of Asia for many years, but decided, in order to generate extensive growth and meet regional standards,…
Celsius42 at Europe's largest medical congress for complementary medicine in Baden Baden
Eschweiler, 23 October 2019. Celsius42 will be present again in 2019 at the Medical Week Baden-Baden (Stand UG-35). The Medical Week (30.10.-3.11.2019) is known as one of the largest congress for…